Ask Dr. Sterling MD
Folks, it’s not this easy. If this proves to be true, it would represent the first unequivocally positive development in this fight. Here’s hoping the actual research findings match this marketing salvo. To be determined.
Simply put from the article: Moderna's candidate COVID-19 vaccine looks to protect 94.5% of those who get it, trial shows.